[Federal Register Volume 80, Number 44 (Friday, March 6, 2015)]
[Notices]
[Pages 12207-12208]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-05318]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Request for a License to Export Deuterium

    Pursuant to Title 10 of the Code of Federal Regulations (10 CFR) 
110.70 (b) ``Public Notice of Receipt of an Application,'' please take 
notice that the U.S. Nuclear Regulatory Commission (NRC) has received 
the following request for an export license. Copies of the request are 
available electronically through the Agencywide Documents Access and 
Management System and can be accessed through the Public Electronic 
Reading Room link http://www.nrc.gov/reading-rm.html at the NRC 
Homepage.
    A request for a hearing or petition for leave to intervene may be 
filed within thirty days after publication of this notice in the 
Federal Register (FR). Any request for hearing or petition for leave to 
intervene shall be served by the requestor or petitioner upon the 
applicant, the Office of the General Counsel, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555; the Office of Secretary, U.S. Nuclear 
Regulatory Commission, Washington, DC 20555; and the Executive 
Secretary, U.S. Department of State, Washington, DC 20520.
    A request for a hearing or petition for leave to intervene may be 
filed with the NRC electronically in accordance with NRC's E-Filing 
rule promulgated in August 2007, 72 FR 49139; Aug. 28, 2007. 
Information about filing electronically is available on the NRC's 
public Web site at http://www.nrc.gov/site-help/e-submittals.html. To 
ensure timely electronic filing, at least five days prior to the filing 
deadline, the petitioner/requestor should contact the Office of the 
Secretary by email at [email protected], or by calling (301) 415-
1677, to request a digital ID certificate and allow for the creation of 
an electronic docket.
    In addition to a request for hearing or petition for leave to 
intervene, written comments, in accordance with 10 CFR 110.81, should 
be submitted within thirty days after publication of this notice in the 
FR to Office of the Secretary, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555, Attention: Rulemaking and Adjudications.
    The information concerning this export license application follows.

[[Page 12208]]



                                         NRC EXPORT LICENSE APPLICATION
                                             Description of Material
----------------------------------------------------------------------------------------------------------------
    Name of applicant date of
   application  date received        Material type      Total quantity          End use        Recipient country
   application no. docket no.
----------------------------------------------------------------------------------------------------------------
Concert Pharmaceuticals, Inc.,    Heavy water (D2O).  ~20,000.0 kgs.....  Non-nuclear end-    Switzerland.
 February 12, 2015, February 20,                                           use in active
 2015, XMAT434, 11006190.                                                  pharmaceutical
                                                                           ingredient
                                                                           manufacturing.
----------------------------------------------------------------------------------------------------------------


    Dated this 26th day of February, 2015 at Rockville, Maryland.

    For the U.S. Nuclear Regulatory Commission.
David L. Skeen,
Deputy Director, Office of International Programs.
[FR Doc. 2015-05318 Filed 3-5-15; 8:45 am]
BILLING CODE 7590-01-P